Similar articles for PMID: 27739924

Year	Number of Results
1993	1
1994	1
1998	2
2001	2
2002	1
2003	1
2004	1
2005	1
2007	1
2008	1
2009	1
2012	1
2013	3
2014	7
2015	9
2016	10
2017	7
2018	6
2019	8
2020	8
2021	3
2022	1
2023	1
2024	0

1

Broadly neutralizing antibodies: An approach to control HIV-1 infection.

Yaseen MM, Yaseen MM, Alqudah MA. Yaseen MM, et al. Int Rev Immunol. 2017 Jan 2;36(1):31-40. doi: 10.1080/08830185.2016.1225301. Epub 2016 Oct 14. Int Rev Immunol. 2017. PMID: 27739924 Review.

2

Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies.

Zhang Z, Li S, Gu Y, Xia N. Zhang Z, et al. Int J Mol Sci. 2016 Nov 18;17(11):1901. doi: 10.3390/ijms17111901. Int J Mol Sci. 2016. PMID: 27869733 Free PMC article. Review.

3

Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic.

Caskey M, Klein F, Nussenzweig MC. Caskey M, et al. Nat Med. 2019 Apr;25(4):547-553. doi: 10.1038/s41591-019-0412-8. Epub 2019 Apr 1. Nat Med. 2019. PMID: 30936546 Free PMC article. Review.

4

Of Mice, Macaques, and Men: Broadly Neutralizing Antibody Immunotherapy for HIV-1.

Nishimura Y, Martin MA. Nishimura Y, et al. Cell Host Microbe. 2017 Aug 9;22(2):207-216. doi: 10.1016/j.chom.2017.07.010. Cell Host Microbe. 2017. PMID: 28799906 Free PMC article. Review.

5

Harnessing Antibody-Dependent Cellular Cytotoxicity To Control HIV-1 Infection.

Abuharfeil NM, Yaseen MM, Alsheyab FM. Abuharfeil NM, et al. ACS Infect Dis. 2019 Feb 8;5(2):158-176. doi: 10.1021/acsinfecdis.8b00167. Epub 2018 Dec 20. ACS Infect Dis. 2019. PMID: 30525453 Review.

6

Broadly Neutralizing Antibodies for HIV Eradication.

Stephenson KE, Barouch DH. Stephenson KE, et al. Curr HIV/AIDS Rep. 2016 Feb;13(1):31-7. doi: 10.1007/s11904-016-0299-7. Curr HIV/AIDS Rep. 2016. PMID: 26841901 Free PMC article. Review.

7

[Trispecific broadly neutralizing antibodies for HIV immunoprophylaxis and immunotherapy?].

Barin F, Stefic K. Barin F, et al. Med Sci (Paris). 2018 Feb;34(2):109-111. doi: 10.1051/medsci/20183402002. Epub 2018 Feb 16. Med Sci (Paris). 2018. PMID: 29451475 Free article. French. No abstract available.

8

Antibody-mediated prevention and treatment of HIV-1 infection.

Gruell H, Klein F. Gruell H, et al. Retrovirology. 2018 Nov 16;15(1):73. doi: 10.1186/s12977-018-0455-9. Retrovirology. 2018. PMID: 30445968 Free PMC article. Review.

9

Focus on the therapeutic efficacy of 3BNC117 against HIV-1: In vitro studies, in vivo studies, clinical trials and challenges.

Liu ZJ, Bai J, Liu FL, Zhang XY, Wang JZ. Liu ZJ, et al. Int Immunopharmacol. 2017 Nov;52:44-50. doi: 10.1016/j.intimp.2017.08.016. Epub 2017 Aug 31. Int Immunopharmacol. 2017. PMID: 28858725 Review.

10

Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants.

Klein F, Nogueira L, Nishimura Y, Phad G, West AP Jr, Halper-Stromberg A, Horwitz JA, Gazumyan A, Liu C, Eisenreich TR, Lehmann C, Fätkenheuer G, Williams C, Shingai M, Martin MA, Bjorkman PJ, Seaman MS, Zolla-Pazner S, Karlsson Hedestam GB, Nussenzweig MC. Klein F, et al. J Exp Med. 2014 Nov 17;211(12):2361-72. doi: 10.1084/jem.20141050. Epub 2014 Nov 10. J Exp Med. 2014. PMID: 25385756 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

73 results

Results by year